New breakout Ready to move upward. It completed the corrective pattern and may follow the previous motive wave. Keep SL at recent swing low i.e, low of wave 4
LongCompare with Mankind Pharma Ltd.
49.50 INR
19.13 B INR
142.78 B INR
113.05 M
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
Company info
Sector
Industry
CEO
Sheetal Arora
Website
Headquarters
New Delhi
Founded
1986
IPO date
May 9, 2023
ISIN
INE634S01028
FIGI
BBG01G9WXG92
Identifiers
ISIN INE634S01028
Mankind Pharma Ltd. engages in the development, manufacture, and marketing of pharmaceutical formulations across acute and chronic therapeutic areas. It offers products under the brands of Nurokind, Telmikind, Manforce, Unwanted, Gudcef, Moxikind, Amlokind, Glimestar, Asthakind, Codistar, Candiforce, Mahacef, Prega News, Dydroboon, Cefakind, Monticope, and Caldikind. The company was founded by Ramesh Chand Juneja, Rajeev Juneja and Prem Kumar Arora in 1986 and is headquartered in New Delhi, India.
Long
MANKIND (D) CHARTTechnical Note: Let the market come to your zones and show its hand. Trade safely and manage your risk! Always wait for your own confirmations before entering the market.
Risk Disclaimer: This analysis is for educational purposes only and does not constitute financial advice. Always practice proper
Long
MANKIND: High-Level Breakout & Bullish EMA Ribbon Alignment 📊 Mankind Pharma Ltd. (MANKIND) - 1-Hour (1H) Chart Analysis
This post is shared for EDUCATIONAL PURPOSES ONLY to analyze short-term continuation breakouts, moving average alignment, and structural price expansion. It is not financial or investment advice.
🎯 Educational Swing Setup:
• Entry Zone:
Long
MANKIND | Buy @LTP | Strict SL below 2480 | Targets 2980, 3460The stock market involves risk, risk, and only risk. To survive in the market, accepting stop-loss with discipline and without hesitation. There is no other way to protect you capital.
Any stock I share is either already part of my existing holding or I take a fresh entry at the same level I mentio
Long
MANKIND - Trading Opportunity in the short termTF: daily
CMP: 2330
Observation:
Price is bouncing from the breakout Retest zone
Price is taking support at the 200 DEMA 50 DEMA confluence zone
Price made a doji at the support and reversal confirmation is in play.
Positional players can enter now and hold. One can wait for another pullback and
MANKIND PHARMA – SWING TO POSITIONAL TRADE SETUP LOADING .......✅ Accumulation Near Key Support
Price is holding the ₹2,300–₹2,340 demand zone.
Previous resistance is attempting to become support.
✅ Multi-Month Trendline Breakout
Long-term descending trendline has been broken.
Signals potential trend reversal after a prolonged correction.
✅ Volume Confirms I
Long
MANKIND - A must consider script in the Pharma spaceCMP: 2520
TF: Daily
Most of the scripts had a great run since covid and they were multiplied by 5-8x since covid.
Since this script listed only in 2024, and didnt move much, and also in the pharma space, i believe that this script has a great potential compared to every other stock in the pharma s
Review and plan for 20th May 2026 Nifty future and banknifty future analysis and intraday plan.
This video is for information/education purpose only. you are 100% responsible for any actions you take by reading/viewing this post.
please consult your financial advisor before taking any action.
----Vinaykumar hiremath, CMT
Amazing INVESTMENT on WEEKLY Timeframe - MANKINDCheckout an amazing breakout happened in the stock in Weekly timeframe, macroscopically seen in Daily timeframe. Having a great favor that the stock might be bullish expecting a staggering returns of minimum 25% TGT. IMPORTANT BREAKOUT LEVELS ARE ALWAYS RESPECTED!
NOTE for learners: Place the break
Long
Chart – MANKIND (Educational View)Sharing this chart for educational purposes and market study.
This is not a buy/sell recommendation. It’s a structured view of current price behavior around key levels.
Focus areas on the chart:
• Market structure
• Key support & resistance zones
• Reaction zones where price is responding
• Possib
See all ideas
Summarizing what the indicators are suggesting.
Neutral
Neutral
Neutral
An aggregate view of professional's ratings.
Neutral
Neutral
Neutral
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently asked questions
The current price of MANKIND is 2,479.40 INR — it has increased by 2.04% in the past 24 hours. Watch Mankind Pharma Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange Mankind Pharma Ltd. stocks are traded under the ticker MANKIND.
MANKIND stock has risen by 8.64% compared to the previous week, the month change is a 3.78% rise, over the last year Mankind Pharma Ltd. has showed a −6.82% decrease.
We've gathered analysts' opinions on Mankind Pharma Ltd. future price: according to them, MANKIND price has a max estimate of 3,220.00 INR and a min estimate of 2,057.00 INR. Watch MANKIND chart and read a more detailed Mankind Pharma Ltd. stock forecast: see what analysts think of Mankind Pharma Ltd. and suggest that you do with its stocks.
MANKIND reached its all-time high on Dec 23, 2024 with the price of 3,050.00 INR, and its all-time low was 1,240.75 INR and was reached on May 22, 2023. View more price dynamics on MANKIND chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
MANKIND stock is 2.46% volatile and has beta coefficient of 0.30. Track Mankind Pharma Ltd. stock price on the chart and check out the list of the most volatile stocks — is Mankind Pharma Ltd. there?
Today Mankind Pharma Ltd. has the market capitalization of 1.00 T, it has increased by 1.28% over the last week.
Yes, you can track Mankind Pharma Ltd. financials in yearly and quarterly reports right on TradingView.
Mankind Pharma Ltd. is going to release the next earnings report on Nov 11, 2026. Keep track of upcoming events with our Earnings Calendar.
MANKIND earnings for the last quarter are 13.80 INR per share, whereas the estimation was 13.31 INR resulting in a 3.71% surprise. The estimated earnings for the next quarter are 17.05 INR per share. See more details about Mankind Pharma Ltd. earnings.
Mankind Pharma Ltd. revenue for the last quarter amounts to 40.31 B INR, despite the estimated figure of 39.66 B INR. In the next quarter, revenue is expected to reach 41.72 B INR.
MANKIND net income for the last quarter is 5.68 B INR, while the quarter before that showed 5.54 B INR of net income which accounts for 0.00% change. Track more Mankind Pharma Ltd. financial stats to get the full picture.
Yes, MANKIND dividends are paid semi-annually. The last dividend per share was 1.00 INR. As of today, Dividend Yield (TTM)% is 0.04%. Tracking Mankind Pharma Ltd. dividends might help you take more informed decisions.
Mankind Pharma Ltd. dividend yield was 0.05% in 2025, and payout ratio reached 2.16%. The year before the numbers were 0.00% and 0.00% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Sep 23, 2026, the company has 27 K employees. See our rating of the largest employees — is Mankind Pharma Ltd. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Mankind Pharma Ltd. EBITDA is 38.27 B INR, and current EBITDA margin is 25.62%. See more stats in Mankind Pharma Ltd. financial statements.
Like other stocks, MANKIND shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Mankind Pharma Ltd. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Mankind Pharma Ltd. technincal analysis shows the strong buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Mankind Pharma Ltd. stock shows the buy signal. See more of Mankind Pharma Ltd. technicals for a more comprehensive analysis.